Furazolidone Prices June 2023
Product
|
Category |
Region |
Price |
Furazolidone |
Pharma API |
USA |
16775 USD/MT |
Furazolidone |
Pharma API |
China |
15844 USD/MT |
Furazolidone |
Pharma API |
Germany |
17788 USD/MT |
The price of furazolidone in the USA reached 16775 USD/MT in June 2023.
In June 2023, the price of furazolidone in China reached 15844 USD/MT.
In Germany, the furazolidone price reached 17788 USD/MT in June 2023.
Furazolidone Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Furazolidone Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of furazolidone pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of furazolidone at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of furazolidone price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing furazolidone price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Furazolidone Market Analysis
The global furazolidone market size is projected to exhibit a growth rate (CAGR) of 3.30% during 2023-2032.
- The furazolidone is gaining traction due to its utilization in treating bacterial infections, especially caused by Gram-negative bacteria. Its demand is further increased by its vital role in gastrointestinal infections.
- According to the IMARC Group’s report, the global veterinary healthcare market reached US$ 43.3 Billion in 2023. To treat and prevent bacterial infections in livestock, poultry, and companion animals, furazolidone is widely used in veterinary medicines. Animal health and productivity can also be maintained with the help of furazolidone.
- The furazolidone demand is further amplified by its cost-effectiveness owing to the presence of generic versions of these drugs. Low and middle-income countries, where healthcare expenditure is limited, it is highly useful.
- As per the report of the World Health Organization (WHO) 2023, it was anticipated that bacterial antimicrobial resistance (AMR) was responsible for 1.27 million global deaths in 2019. With the rising prevalence of bacterial AMR, there is a growing need for alternative antimicrobial agents that can help in treating resistant bacteria, and furazolidone fits in this demand perfectly.
- The furazolidone market share is further being reinforced as healthcare providers are seeking alternatives to conventional antibiotics. Furazolidone has unique mechanism of action and effectiveness that can combat certain resistant strains.
- Furazolidone production is showing an upward trajectory on account of its utilization to prevent bacterial infections in fish and other aquatic animals. Bacterial contamination in food-producing animals can only be prevented by furazolidone, thus driving its demand worldwide.
- A positive trend of the market is being created as there is a rise in the demand for furazolidone for disease control in plants in the agriculture sector. The negative impact in crop yield because of bacterial and fungal infections in plants underscores the importance of furazolidone to prevent these infections.
- The market is also expanding due to the rising utilization of furazolidone in wastewater treatment around the world. In wastewater plants, furazolidone helps in degrading pollutants and reducing bacterial contamination.
Furazolidone News
The report covers the latest developments, updates, and trends impacting the global furazolidone market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in furazolidone production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the furazolidone price trend.
Latest developments in the furazolidone industry:
- In 2024, BD (Becton, Dickinson and Company), a leading global medical technology company, announced a strategic partnership with Camtech Health, a digital health company focused on at-home health testing, to advance cervical cancer screening by offering the first-ever option for women in Singapore to self-collect a sample in the privacy of their own home.
- In 2024, Daiichi Sankyo announced to invest around EUR one billion on the project, which will bring leading international researchers, engineers and sterile- and bio-technology experts to the Bavarian town for increasing its production capacities for cardiovascular medications.
Product Description
Furazolidone, a synthetic nitrofuran derivative, is well-known for its broad-spectrum antibacterial activities and versatility in human and veterinary medicine. Its nitrofuran ring structure gives it antibacterial and antiprotozoal activity, making it useful in the fight against a variety of infectious disorders. Its effectiveness as an antibacterial agent stems from its ability to block microbial enzymes required for nucleic acid production, which aids in the prevention of bacterial growth. It is widely used in the treatment and prevention of infections, which adds to its effectiveness against a variety of bacterial and protozoal pathogens.
To treat gastrointestinal infections, traveler’s diarrhea, and other bacterial and protozoal diseases in humans, furazolidone is highly effective. It also finds applications in the agriculture industry to protect plants and crops from the negative impact of bacterial infection.
Regional Coverage
The report provides a detailed analysis of the furazolidone market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the furazolidone price trend.
Global Furazolidone Price
The report offers a holistic view of the global furazolidone pricing trends in the form of furazolidone price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of furazolidone but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed furazolidone demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Furazolidone Price
European furazolidone prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed furazolidone price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Furazolidone Price
The analysis of furazolidone prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific furazolidone historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Furazolidone Price
The report explores the furazolidone pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on furazolidone prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Furazolidone Price
The furazolidone pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This furazolidone price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Furazolidone Price
The analysis of furazolidone prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Furazolidone |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Furazolidone Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of furazolidone pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting furazolidone price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The furazolidone price charts ensure our clients remain at the forefront of the industry.